Related content

Acquired resistance mechanisms to tyrosine kinase inhibitors in lung cancer with activating epidermal growth factor receptor mutation-diversity, ductility, and destiny

By Suda Kenichi  

Cancer and Metastasis Reviews, Vol. 31, Iss. 3-4, 2012-12 ,pp. : 807-814

Springer Publishing Company

Access to resources Recommend Favorite

Differential efficacy of docetaxel according to nonsmall cell lung cancer histology and the therapeutic effect of epidermal growth factor receptor tyrosine kinase inhibitors

By                                

Oncology Letters, Vol. 2, Iss. 6, 2011-01 ,pp. : 1059-1064

Spandidos Publications

Access to resources Recommend Favorite

Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitors from the Natural Origin: A Recent Perspective

By  

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 15, Iss. 8, 2015-01 ,pp. : 988-1011

Bentham Science Publishers

Access to resources Recommend Favorite

Primary and Acquired Resistance to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Non-small Cell Lung Cancer: An Update

By Ayoola Ayodele   Barochia Amit   Belani Kiran   Belani Chandra P.  

Cancer Investigation, Vol. 30, Iss. 5, 2012-05 ,pp. : 433-446

Informa Healthcare

Access to resources Recommend Favorite

Evaluation of Novel Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors

By Rae James M.  

Breast Cancer Research and Treatment, Vol. 83, Iss. 2, 2004-01 ,pp. : 99-107

Springer Publishing Company

Access to resources Recommend Favorite